StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
6-factor scoring with sector-relative rank. Updated daily.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $90.52 | $89.00 | -1.68% | 0.3M |
| 05-12 | $89.00 | $84.28 | -5.30% | 0.2M |
| 05-13 | $83.56 | $83.22 | -0.41% | 0.2M |
| 05-14 | $84.28 | $85.37 | +1.29% | 0.1M |
| 05-15 | $84.87 | $83.10 | -2.09% | 0.2M |
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
PLUS reports on 2026-05-27 after market close. Things to look at before the print:
Educational pre-print checklist — descriptive only, not a directional call.
Each factor shows PLUS's percentile within the scored universe — observational ranking, not a recommendation.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q2 2026 (Est.) Expected 2026-05-27 | Annual 2018 2018-03-31 | Annual 2017 2017-12-31 | Annual 2017 2017-09-30 | Annual 2017 2017-06-30 |
|---|---|---|---|---|---|
Revenue | $580.63M | $1.41B | $342.57M | $370.85M | $367.16M |
Operating Income | Not available | $84.24M | $16.39M | $28.83M | $20.51M |
Net Income | Not available | $55.12M | $15.58M | $17.22M | $13.42M |
EPS (Diluted) | $1.00 | $3.95 | $1.11 | $1.23 | $0.96 |
Total Assets | Not available | $755.47M | $760.51M | $734.29M | $755.18M |
Total Liabilities | Not available | $382.87M | $381.04M | $362.93M | $398.15M |
Cash & Equivalents | Not available | $118.20M | $76.11M | $60.19M | $98.24M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 13.76M | 14.05M | 14.17M | 14.17M |
What you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
PLUS is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1138-name primary list.
DNA analysis is not available for this ticker.